Enhancing the reputation of the pharmaceutical industry, improving access to innovative medicines for NHS patients and ensuring a UK environment that enables the Life Sciences industry to thrive are the three key priorities for Lisa Anson as she begins her two-year Presidency of the Association of...
Erik Nordkamp, Managing Director of Pfizer UK explains why Pfizer has partnered with the Science Museum to sponsor its new exhibition on antibiotic resistance.
Following the news that the UK has succeeded in eliminating measles, Dr Emma St Clair Pearce, the ABPI’s newly appointed Research and Collaboration Policy Officer, writes that while the UK’s success of limiting the spread of the virus through vaccination should be heralded, national figures for MMR...
The Association of the British Pharmaceutical Industry (ABPI) have responded to an announcement made today by Health Minister Lord O’Shaughnessy to spend £86 million "to help develop real world medical breakthroughs that will help patients across the NHS."
Dr Sheuli Porkess, ABPI's Head of Medical Affairs, says:
The Association of the British Pharmaceutical Industry (ABPI) and a group of leaders from ABPI member companies have joined more than 1,280 business executives, including directors from 51 FTSE 100 companies, in signing a letter backing the UK's membership of the EU.
The Association of British Pharmaceutical Industry (ABPI) welcomes the strong focus on science and innovation in the Government's green paper on Industrial Strategy, set out today by the Prime Minister. This is further demonstration of their support for research and development which is a...
Following publication of ‘The United Kingdom’s Exit from, and New Partnership with, the European Union’ White Paper, the Association of the British Pharmaceutical Industry (ABPI) has issued the following statement.
The Association of the British Pharmaceutical Industry (ABPI) has responded to today’s triggering of Article 50 of the Lisbon Treaty by Prime Minister Theresa May, officially starting the process of the United Kingdom (UK) negotiating its departure from the European Union (EU).
The Association of the British Pharmaceutical Industry (ABPI) has added its weight to calls from leading experts and policy makers in British science that leaving the European Union would put UK science "at risk".